Quiescence regulators for hematopoietic stem cell

Experimental Hematology

Volumn 39, Issue 5, 2011, Pages 511-520

  Li, June ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; BONE MORPHOGENETIC PROTEIN; CALCIUM ION; CYCLIN DEPENDENT KINASE INHIBITOR; INTEGRIN; INTERFERON REGULATORY FACTOR 2; NERVE CELL ADHESION MOLECULE; NUCLEAR RECEPTOR RELATED FACTOR 1; OSTEOPONTIN; PROTEIN CDC42; PROTEIN GFI1; PROTEIN P21; PROTEIN P53; PROTEIN P57; REACTIVE OXYGEN METABOLITE; SONIC HEDGEHOG PROTEIN; STAT5 PROTEIN; STEM CELL FACTOR; THIOREDOXIN INTERACTING PROTEIN; THROMBOPOIETIN; THROMBOPOIETIN RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR PBX1; TRANSCRIPTION FACTOR TAL1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; BONE MARROW; CELL CYCLE REGULATION; CELL HYPOXIA; CELL PROLIFERATION; DORMANCY; GENE MUTATION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MICROENVIRONMENT; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 79955146247     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2011.01.008     Document Type: Review

References (118)

1. Enver T., Heyworth C.M., Dexter T.M. Do stem cells play dice?. Blood 1998, 92:348-351.
2. Wilson A., Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol 2006, 6:93-106.
3. Cheng T., Rodrigues H., Shen Y., et al. Hematopoietic stem cell quiescence maintained by 21cip1/waf1. Science 2000, 287:1804-1808.
4. Essers M.A., Offner S., Blanco-Bose W.E., et al. IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 2009, 458:904-908.
5. Venezia T.A., Merchant A.A., Ramos C.A., et al. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol 2004, 2:e301.
6. Randall T.D., Weissman I.L. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood 1997, 89:3596-3606.
7. Li L., Xie T. Stem cell niche: structure and function. Annu Rev Cell Dev Biol 2005, 21:605-631.
8. Till J.E., McCulloch E.A., Siminovitch L. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc Natl Acad Sci U S A 1964, 51:29-36.
9. Metcalf D. Hematopoietic regulators: redundancy or subtlety?. Blood 1993, 82:3515-3523.
10. Suda T., Arai F., Hirao A. Hematopoietic stem cells and their niche. Trends Immunol 2005, 26:426-433.
11. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978, 4:7-25.
12. Lin H. The stem-cell niche theory: lessons from flies. Nat Rev Genet 2002, 3:931-940.
13. Fuchs E., Tumbar T., Guasch G. Socializing with the neighbors: stem cells and their niche. Cell 2004, 116:769-778.
14. Moore K.A., Lemischka I.R. Stem cells and their niches. Science 2006, 311:1880-1885.
15. Adams G.B., Scadden D.T. The hematopoietic stem cell in its place. Nat Immunol 2006, 7:333-337.
16. Spradling A., Drummond-Barbosa D., Kai T. Stem cells find their niche. Nature 2001, 414:98-104.
17. Kopp H.G., Avecilla S.T., Hooper A.T., Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda) 2005, 20:349-356.
18. Avecilla S.T., Hattori K., Heissig B., et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004, 10:64-71.
19. Walkley C.R., Olsen G.H., Dworkin S., et al. A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell 2007, 129:1097-1110.
20. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003, 425:841-846.
21. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003, 425:836-841.
22. Visnjic D., Kalajzic Z., Rowe D.W., Katavic V., Lorenzo J., Aguila H.L. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 2004, 103:3258-3264.
23. Thoren L.A., Liuba K., Bryder D., et al. Kit regulates maintenance of quiescent hematopoietic stem cells. J Immunol 2008, 180:2045-2053.
24. Czechowicz A., Kraft D., Weissman I.L., Bhattacharya D. Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches. Science 2007, 318:1296-1299.
25. Kiel M.J., Morrison S.J. Maintaining hematopoietic stem cells in the vascular niche. Immunity 2006, 25:862-864.
26. Barker J.E. Sl/Sld hematopoietic progenitors are deficient in situ. Exp Hematol 1994, 22:174-177.
27. Nilsson S.K., Johnston H.M., Coverdale J.A. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001, 97:2293-2299.
28. Arai F., Hirao A., Ohmura M., et al. Tie2/Angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 2007, 118:149-161.
29. Solar G.P., Kerr W.G., Zeigler F.C., et al. Role of c-mpl in early hematopoiesis. Blood 1998, 92:4-10.
30. Qian H., Buza-Vidas N., Hyland C.D., et al. Critical role of thrombopoietin in maintaining adult quiescent hematopoietic stem cells. Cell Stem Cell 2007, 1:599-600.
31. Yoshihara H., Arai F., Hosokawa K., et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. Cell Stem Cell 2007, 1:599-600.
32. Bersenev A., Wu C., Balcerek J., Tong W. Lnk controls mouse hematopoietic stem cell self-renewal and quiescence through direct interactions with JAK2. J Clin Invest 2008, 118:2832-2844.
33. Kubota Y., Takubo K., Suda T. Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche. Biochem Biophys Res Commun 2008, 366:335-339.
34. Parmar K., Mauch P., Vergilio J.A., Sackstein R., Down J.D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A 2007, 104:5431-5436.
35. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
36. Puch S., Armeanu S., Kibler C., et al. N-cadherin is developmentally regulated and functionally involved in early hematopoietic cell differentiation. J Cell Sci 2001, 114:1567-1577.
37. Silver I.A., Murrills R.J., Etherington D.J. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988, 175:266-276.
38. Zhu J., Emerson S.G. A new bone to pick: osteoblasts and the haematopoietic stem-cell niche. Bioessays 2004, 26:595-599.
39. Kiel M.J., Acar M., Radice G.L., Morrison S.J. Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance. Cell Stem Cell 2009, 4:170-179.
40. Kiel M.J., Radice G.L., Morrison S.J. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cell 2007, 1:127-129.
41. Haug J.S., He X.C., Grindley J.C., et al. N-cadherin expression level distinguishes reserved versus primed states of hematopoietic stem cells. Cell Stem Cell 2008, 4:367-379.
42. Reinholt F.P., Hultenby K., Oldberg A., Heinegard D. Osteopontin: a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A 1990, 87:4473-4475.
43. Stier S., Ko Y., Forkert R., Lutz C., et al. Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size. J Exp Med 2005, 201:1781-1791.
44. Nilsson S.K., Johnston H.M., Whitty G.A., et al. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood 2005, 106:1232-1239.
45. Adams G.B., Chabner K.T., Alley I.R., et al. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature 2006, 439:599-603.
46. Ross J., Li L. Recent advances in understanding extrinsic control of hematopoietic stem cell fate. Curr Opin Hematol 2006, 13:237-242.
47. Blank U., Karlsson G., Karlsson S. Signaling pathways governing stem cell fate. Blood 2008, 111:492-503.
48. Sitnicka E., Ruscetti F.W., Priestley G.V., Wolf N.S., Bartelmez S.H. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood 1996, 88:82-88.
49. Batard P., Monier M.N., Fortunel N., et al. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 2000, 113:3383-3390.
50. Garbe A., Spyridonidis A., Mobest D., Schmoor C., Mertelsmann R., Henschler R. Transforming growth factor-beta 1 delays formation of granulocyte- macrophage colony-forming cells, but spares more primitive progenitors during ex vivo expansion of CD34 haemopoietic progenitor cells. Br J Haematol 1997, 99:951-958.
51. Hatzfeld J., Li M.L., Brown E.L., et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J Exp Med 1991, 174:925-929.
52. Fortunel N., Batard P., Hatzfeld A., et al. High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells. J Cell Sci 1998, 111:131867-131875.
53. Soma T., Yu J.M., Dunbar C.E. Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-beta but not macrophage inflammatory protein-1 alpha activities. Blood 1996, 87:4561-4567.
54. Jacobsen S.E., Ruscetti F.W., Dubois C.M., Wine J., Keller J.R. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 1991, 77:1706-1716.
55. Dubois C.M., Ruscetti F.W., Stankova J., Keller J.R. Transforming growth factor- beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 1994, 83:3138-3145.
56. Sansilvestri P., Cardoso A.A., Batard P., et al. Early CD34 high cells can be separated into KIT high cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KIT low cells in which anti-TGF-beta upmodulates c-kit. Blood 1995, 86:1729-1735.
57. Ducos K., Panterne B., Fortunel N., Hatzfeld A., Monier M.N., Hatzfeld J. p21(cip1) mRNA is controlled by endogenous transforming growth factor- beta1 in quiescent human hematopoietic stem/progenitor cells. J Cell Physiol 2000, 184:80-85.
58. Cheng T., Shen H., Rodrigues N., Stier S., Scadden D.T. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). Blood 2001, 98:3643-3649.
59. Dao M.A., Taylor N., Nolta J.A. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc Natl Acad Sci U S A 1998, 95:13006-13011.
60. Dao M.A., Hwa J., Nolta J.A. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(progenitors. Blood 2002, 99:499-506.
61. Larsson J., Blank U., Klintman J., Magnusson M., Karlsson S. Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-beta signaling in vivo. Exp Hematol 2005, 33:592-596.
62. Nemeth M.J., Topol L., Anderson S.M., Yang Y., Bodine D.M. Wnt5a inhibits Wnt signaling in hematopoietic stem cells and enhances repopulation. Proc Natl Acad Sci U S A 2007, 104:15436-15441.
63. Fleming H.E., Janzen V., Lo Celso C., et al. Wnt signaling in the niche enforces hematopoietic stem cell quiescence and is necessary to preserve self-renewal in vivo. Cell Stem Cell 2008, 2:274-283.
64. Nemeth M., Mak K.K., Yang Y., Bodine D.M. β-catenin expression in the bone marrow microenvironment is required for long-term maintenance of primitive hematopoietic cells. Stem Cells 2009, 27:1109-1119.
65. Trowbridge J.J., Scott M.P., Bhatia M. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. PNAS 2006, 103:14134-14139.
66. Zhao C., Chen A., Jamieson C.H., et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 2009, 458:776-779.
67. Hofmann I., Stover E.H., Cullen D.E., et al. Hedgehog signaling is dispensable for adult marine hematopoietic stem cell function and hematopoietic. Cell Stem Cell 2009, 4:559-567.
68. Schmidt T., Zornig M., Beneke R., Mr T. MoMuLV proviral integrations identified by Sup-F selection in tumors from infected myc/pim bitransgenic mice correlate with activation of the gfi-1 gene. Nucleic Acids Res 1996, 24:2528-2534.
69. Hock H., Hamblen M.J., Rooke H.M., et al. Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells. Nature 2004, 431:1002-1007.
70. Zeng H., Yucel R., Kosan C., Klein-Hitpass L., Mry T. Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J 2004, 23:4116-4125.
71. DiMartino J.F., Selleri L., Traver D., et al. The Hox cofactor and protooncogene. Pbx1 is required for maintenance of definitive hematopoiesis in the fetal liver. Blood 2001, 98:618-626.
72. Forsberg E.C., Prohaska S.S., Katzman S., et al. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet 2005, 1:e28.
73. Kiel M.J., Yilmaz O.H., Iwashita T., Yilmaz O.H., Terhorst C., Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 2005, 121:1109-1121.
74. Ficara F., Murphy M.J., Lin M., Cleary M.L. Pbx1 regulates self-renewal of long- term hematopoietic stem cells by maintaining their quiescence. Cell Stem Cell 2008, 2:484-496.
75. Shaulsky G., Goldfinger N., Peled A., Rotter V. Involvement of wild-type p53 in pre-B-cell differentiation in vitro. Proc Natl Acad Sci U S A 1991, 88:8982-8986.
76. Shounan Y., Dolnikov A., MacKenzie K.L., Miller M., Chan Y.Y., Symonds G. Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. Leukemia 1996, 19:1619-1628.
77. Kastan M.B., Radin A.I., Kuerbitz S.J., et al. Levels of p53 protein increase with maturation in human hematopoietic cells. Cancer Res 1991, 51:4279-4286.
78. Lotem J., Sachs L. Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 1993, 82:1092-1096.
79. Guzman M.L., Swiderski C.F., Howard D.S., et al. Preferential induction of apoptosis for primary human leukemic stem cells. Proc Natl Acad Sci U S A 2002, 99:16220-16225.
80. Dumble M., Moore L., Chambers S.M., et al. The impact of altered p53 dosage on Hematopoietic stem cell dynamics during aging. Blood 2007, 109:1736-1742.
81. Liu Y., Elf S.E., Miyata Y., et al. Cell. p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 2009, 4:37-48.
82. Lacorazza H.D., Miyazaki Y., Di Cristofano A., et al. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity 2002, 17:437-449.
83. Lacombe J., Herblot S., Rojas-Sutterlin S., et al. Scl regulates the quiescence and the long-term competence of hematopoietic stem cells. Blood 2010, 115:792-803.
84. Sato T., Onai N., Yoshihara H., Arai F., Suda T., Ohteki T. Interferon regulatory factor-2 protects quiescent hematopoietic stem cells from type I interferon-dependent exhaustion. Nat Med 2009, 15. 696-670.
85. Sirin O., Lukov G.L., Mao R., Conneely O.M., Goodell M.A. The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells. Nat Cell Biol 2010, 12:1213-1219.
86. Shao Y., Kim S.Y., Shin D., et al. TXNIP regulates germinal center generation by suppressing BCL-6 expression. Immunol Lett 2010, 2:78-84.
87. Ezoe S., Matsumura I., Nakata S., et al. GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. Blood 2002, 100:3512-3520.
88. Venezia T.A., Merchant A.A., Ramos C.A., et al. Molecular signatures of proliferation and quiescence in hematopoietic stem cells. PLoS Biol 2004, 2:301.
89. Tipping A.J., Pina C., Castor A., et al. High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. Blood 2009, 113:2661-2672.
90. Serrano M., Hannon G.J., Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993, 366:704-707.
91. Harper J.W., Adami G.R., Wei K.K., Elledge S.J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993, 75:805-816.
92. Stier S., Cheng T., Forkert R., et al. Ex vivo targeting of p21Cip1/Waf1 permits relative expansion of human hematopoietic stem cells. Blood 2003, 102:1260-1266.
93. Cheng T., Rodrigues N., Shen H., et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000, 287:1804-1808.
94. Zhang J., Attar E., Cohen K., Crumpacker C., Scadden D. Silencing p21(Waf1/Cip1/Sdi1) expression increases gene transduction efficiency in primitive human hematopoietic cells. Gene Therapy 2005, 12:1444-1452.
95. Zhang P., Liegeois N.J., Wong C., et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in BeckwithWiedemann syndrome. Nature 1997, 387:151-158.
96. Umemoto T., Yamato M., Nishida K., et al. p57Kip2 is expressed in quiescent mouse bone marrow side population cells. Biochem Biophys Res Commun 2005, 337:14-21.
97. Scandura J.M., Boccuni P., Massagu J., Nimer S.D. Transforming growth factor β-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci U S A 2004, 101:15231-15236.
98. Yang L., Wang L., Geiger H., Cancelas J.A., Mo J., Zheng Y. Rho GTPase Cdc42 coordinates hematopoietic stem cell quiescence and niche interaction in the bone marrow. Proc Natl Acad Sci U S A 2007, 104:5091-5096.
99. Thompson B.J., Jankovic V., Gao J., et al. Control of hematopoietic stem cell quiescence by the E3 ubiquitin ligase Fbw7. J Exp Med 2008, 205:1395-1408.
100. Zhang J., Grindley J.C., Yin T., et al. PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature 2006, 441:518-522.
101. Yilmaz O.H., Valdez R., Theisen B.K., et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 2006, 441:475-482.
102. Ito K., Bernardi R., Morotti A., et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 2008, 453(7198):1072-1078.
103. Chen C., Liu Y., Liu R., et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 2008, 205:2397-2408.
104. Ito K., Hirao A., Arai F., et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat Med 2006, 12:446-451.
105. Ito K., Takubo K., Arai F., et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
106. Tothova Z., Kollipara R., Huntly B.J., et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007, 128:325-339.
107. Miyamoto K., Araki K.Y., Naka K., et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell 2007, 1:101-112.
108. Wang Z., Li G., Tse W., Bunting K.D. Conditional deletion of STAT5 in adult mouse hematopoietic stem cells causes loss of quiescence and permits efficient nonablative stem cell replacement. Blood 2009, 113:4856-4865.
109. Viatour P., Somervaille T.C., Venkatasubrahmanyam S., et al. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 2008, 3:416-428.
110. Yoshida T., Hazan I., Zhang J., et al. The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation. Genes Dev 2008, 22:1174-1189.
111. Gan B., Hu J., Jiang S., et al. Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells. Nature 2010, 468:701-704.
112. Wilson A., Murphy M.J., Oskarsson T., et al. c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004, 18:2747-2763.
113. Fuchs E.J., Whartenby K.A. Hematopoietic stem cell transplant as a platform for tumor immunotherapy. Curr Opin Mol Ther 2006, 6:48-53.
114. Moore K.A., Lemischka I.R. Stem cells and their niches. Science 2006, 311:1880-1885. Review.
115. Forsberg E.C., Passegu E., Prohaska S.S., et al. Molecular signatures of quiescent, mobilized and leukemia-initiating hematopoietic stem cells. PLoS One 2010, 20(1). e8785-e8785.
116. Hillion J., Le Coniat M., Jonveaux P., Berger R., Bernard O.A. AF6q21, a novel partner of the MLL gene in t(6;11)(q21;q23), defines a forkhead transcriptional factor subfamily. Blood 1997, 90:3714-3719.
117. Borkhardt A., Repp R., Haas O.A., et al. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukemias with a t(X;11)(q13;q23). Oncogene 1997, 14:195-202.
118. Wang C.Q., Jacob B., Nah G.S., Osato M. Runx family genes, niche, and stem cell quiescence. Blood Cells Mol Dis 2010, 44:275-286.